RadNet, Inc. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax
RadNet, Inc. (RDNT) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax of -$2.27 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax · last filed 2026-08-10
- RadNet, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-12-31 was $0.00.
- RadNet, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-09-30 was -$217.00K.
- RadNet, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-06-30 was -$1.02M.
- RadNet, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-03-31 was -$1.03M.
- RadNet, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2025 was -$2.27M.
- RadNet, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2024 was -$9.35M.
- RadNet, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2023 was -$3.58M.
- RadNet, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2022 was -$3.69M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$217.00K derived: sum of 2 quarters · filed 2026-03-02 | -$1.24M derived: sum of 3 quarters · filed 2026-08-10 | -$2.27M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$217.00K 10-Q · filed 2025-11-10 | -$1.24M derived: sum of 2 quarters · filed 2026-08-10 | -$2.27M 10-Q · filed 2025-11-10 | -$3.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$1.02M 10-Q · filed 2026-08-10 | -$2.06M 10-Q · filed 2026-08-10 | -$3.17M derived: sum of 3 quarters · filed 2026-08-10 | -$4.15M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$1.03M 10-Q · filed 2026-05-11 | -$2.14M derived: sum of 2 quarters · filed 2026-05-11 | -$3.13M derived: sum of 3 quarters · filed 2026-05-11 | -$9.65M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$2.10M derived: sum of 2 quarters · filed 2026-03-02 | -$8.61M derived: sum of 3 quarters · filed 2026-03-02 | -$9.35M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$986.00K 10-Q · filed 2025-11-10 | -$7.50M derived: sum of 2 quarters · filed 2025-11-10 | -$8.24M 10-Q · filed 2025-11-10 | -$9.05M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$6.52M 10-Q · filed 2025-08-11 | -$7.26M 10-Q · filed 2025-08-11 | -$8.07M derived: sum of 3 quarters · filed 2026-03-02 | -$8.99M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$739.00K 10-Q · filed 2025-05-12 | -$1.55M derived: sum of 2 quarters · filed 2026-03-02 | -$2.47M derived: sum of 3 quarters · filed 2026-03-02 | -$3.39M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$811.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$1.73M derived: sum of 2 quarters · filed 2026-03-02 | -$2.65M derived: sum of 3 quarters · filed 2026-03-02 | -$3.58M 10-K · filed 2026-03-02 |
| 2023-09-30 | -$921.00K 10-Q · filed 2024-11-12 | -$1.84M derived: sum of 2 quarters · filed 2024-11-12 | -$2.77M 10-Q · filed 2024-11-12 | -$3.68M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$922.00K 10-Q · filed 2024-08-09 | -$1.84M 10-Q · filed 2024-08-09 | -$2.76M derived: sum of 3 quarters · filed 2025-03-03 | -$3.68M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$922.00K 10-Q · filed 2024-05-10 | -$1.84M derived: sum of 2 quarters · filed 2025-03-03 | -$2.76M derived: sum of 3 quarters · filed 2025-03-03 | -$3.69M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$916.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.84M derived: sum of 2 quarters · filed 2025-03-03 | -$2.76M derived: sum of 3 quarters · filed 2025-03-03 | -$3.69M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$924.00K 10-Q · filed 2023-11-09 | -$1.85M derived: sum of 2 quarters · filed 2023-11-09 | -$2.77M 10-Q · filed 2023-11-09 | -$3.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$924.00K 10-Q · filed 2023-08-09 | -$1.85M 10-Q · filed 2023-08-09 | -$2.78M derived: sum of 3 quarters · filed 2024-02-29 | -$3.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$923.00K 10-Q · filed 2023-05-10 | -$1.85M derived: sum of 2 quarters · filed 2024-02-29 | -$2.77M derived: sum of 3 quarters · filed 2024-02-29 | -$3.69M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$1.85M derived: sum of 2 quarters · filed 2024-02-29 | -$2.77M derived: sum of 3 quarters · filed 2024-02-29 | -$3.69M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$920.00K 10-Q · filed 2022-11-09 | -$1.84M derived: sum of 2 quarters · filed 2022-11-09 | -$2.77M 10-Q · filed 2022-11-09 | -$4.35M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$920.00K 10-Q · filed 2022-08-09 | -$1.84M 10-Q · filed 2022-08-09 | -$3.43M derived: sum of 3 quarters · filed 2023-03-01 | -$4.40M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$925.00K 10-Q · filed 2022-05-10 | -$2.51M derived: sum of 2 quarters · filed 2023-03-01 | -$3.48M derived: sum of 3 quarters · filed 2023-03-01 | -$4.37M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.56M derived: sum of 2 quarters · filed 2023-03-01 | -$3.45M derived: sum of 3 quarters · filed 2023-03-01 | -$3.45M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$969.00K 10-Q · filed 2021-11-09 | -$1.86M derived: sum of 2 quarters · filed 2021-11-09 | -$1.86M 10-Q · filed 2021-11-09 | -$1.86M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$892.00K 10-Q · filed 2021-08-09 | -$892.00K 10-Q · filed 2021-08-09 | -$892.00K derived: sum of 3 quarters · filed 2022-03-01 | -$892.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |